Advanced Enzyme Tech balance sheet

As of Mar 2026

Total assets: ₹1,839cr+13.4% on Mar 2025
Shareholders' equity: ₹1,683cr+14.6% on Mar 2025
Total debt: ₹20.5cr−4.7% on Mar 2025
Cash and investments: ₹693cr+20.6% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	276	293	277	273
	51.2	21.7	30.7	15.6
	369	333	325	321
	46.9	52.3	47.9	55.0
	0.0	0.0	10.4	5.9
	0.1	0.1	0.2	0.2
	0.1	0.1	0.0	0.0
	9.7	9.9	4.2	4.2
	9.8	10.0	4.4	4.3
	4.9	10.2	26.6	11.3
	37.1	20.9	3.9	13.5
	795	741	726	700
	177	157	148	124
	584	480	403	360
	145	115	98.6	100
	109	94.2	114	96.4
	7.2	13.5	29.7	26.9
	0.2	0.1	0.1	0.1
	8.6	8.0	3.2	2.9
	854	711	648	586
	12.6	11.1	12.8	10.8
	1,044	880	810	722
	1,839	1,621	1,535	1,422
Equity
	22.4	22.4	22.4	22.4
	1,610	1,398	1,302	1,213
	1,632	1,421	1,324	1,235
	51.2	47.8	47.0	49.1
	1,683	1,469	1,371	1,284
Liabilities
	7.9	9.2	7.0	7.8
	3.8	11.7	15.9	—
	11.7	20.9	22.8	7.8
	5.4	1.4	0.9	0.5
	31.9	33.6	34.3	37.2
	—	0.0	0.0	14.6
	48.9	55.9	58.0	60.1
	12.6	12.4	18.2	5.4
	40.0	17.2	15.8	24.2
	36.2	32.7	30.0	26.5
	88.8	62.3	64.0	56.2
	6.4	21.4	19.7	3.7
	1.0	4.6	9.1	1.5
	10.5	8.5	13.6	16.2
	107	96.8	106	77.6
	156	153	164	138
	1,839	1,621	1,535	1,422
Assets — additional as-filed lines
	12.6	0.0	0.3	1.1
Trade payables — MSME split
	6.4	4.3	—	—
	33.6	12.9	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ADVENZYMES₹264.15

Advanced Enzyme Tech Ltd.

· Pharma & Health

₹ CrorePeersAARTIPHARM AARTIDRUGS AGARWALEYE AKUMS ALIVUS APLLTD CORONA HCGMcap ₹2,956 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	273.2	276.5	292.9	275.8	275.8
+ Capital Work-in-Progress	15.6	30.7	21.7	51.2	51.2
+ Goodwill	320.9	325.3	333.4	369.5	369.5
+ Other Intangibles	55.0	47.9	52.3	46.9	46.9
+ Intangibles under Development	5.9	10.4	0.0	0.0	0.0
+ Non-current Investments	0.2	0.2	0.1	0.1	0.1
+ Long-term Loans	0.0	0.0	0.1	0.1	0.1
+ Other Non-current Financial Assets	4.2	4.2	9.9	9.7	9.7
Non-current Financial Assets	4.3	4.4	10.0	9.8	9.8
+ Deferred Tax Assets	11.3	26.6	10.2	4.9	4.9
+ Other Non-current Assets	13.5	3.9	20.9	37.1	37.1
Total Non-current Assets	699.7	725.7	741.5	795.2	795.2
Current Assets
+ Inventories	124.0	148.5	157.3	177.3	177.3
+ Current Investments	359.6	402.9	480.3	583.8	583.8
+ Trade Receivables	100.3	98.6	115.4	145.0	145.0
+ Cash & Cash Equivalents	96.4	113.8	94.2	108.8	108.8
+ Other Bank Balances	26.9	29.7	13.5	7.2	7.2
+ Short-term Loans	0.1	0.1	0.1	0.2	0.2
+ Other Current Financial Assets	2.9	3.2	8.0	8.6	8.6
Current Financial Assets	586.3	648.2	711.5	853.6	853.6
+ Other Current Assets	10.8	12.8	11.1	12.6	12.6
Total Current Assets	722.1	809.7	879.9	1,043.6	1,043.6
Total Assets	1,421.8	1,535.5	1,621.3	1,838.8	1,838.8
Equity
+ Equity Share Capital	22.4	22.4	22.4	22.4	22.4
+ Other Equity / Reserves	1,212.7	1,301.8	1,398.5	1,609.6	1,609.6
Equity — Owners of Parent	1,235.1	1,324.1	1,420.9	1,632.0	1,632.0
+ Minority Interest	49.1	47.0	47.8	51.2	51.2
Total Equity	1,284.2	1,371.1	1,468.7	1,683.1	1,683.1
Liabilities
+ Borrowings — Non-current	7.8	7.0	9.2	7.9	7.9
+ Other Non-current Financial Liab	—	15.9	11.7	3.8	3.8
Non-current Financial Liabilities	7.8	22.8	20.9	11.7	11.7
+ Provisions — Non-current	0.5	0.9	1.4	5.4	5.4
+ Deferred Tax Liabilities	37.2	34.3	33.6	31.9	31.9
+ Other Non-current Liabilities	14.6	0.0	0.0	—	—
Non-current Liabilities	60.1	58.0	55.9	48.9	48.9
+ Borrowings — Current	5.4	18.2	12.4	12.6	12.6
+ Trade Payables	24.2	15.8	17.2	40.0	40.0
+ Other Current Financial Liab	26.5	30.0	32.7	36.2	36.2
Current Financial Liabilities	56.2	64.0	62.3	88.8	88.8
+ Provisions — Current	3.7	19.7	21.4	6.4	6.4
+ Current Tax Liabilities	1.5	9.1	4.6	1.0	1.0
+ Other Current Liabilities	16.2	13.6	8.5	10.5	10.5
Current Liabilities	77.6	106.4	96.8	106.7	106.7
Total Liabilities	137.7	164.4	152.7	155.6	155.6
Total Equity & Liabilities	1,421.8	1,535.5	1,621.3	1,838.8	1,838.8
Assets — additional as-filed lines
+ Current Tax Assets	1.1	0.3	0.0	12.6	12.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	4.3	6.4	6.4
+ Dues to Other Creditors — Current	—	—	12.9	33.6	33.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.